• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[CerbB-2与激素非依赖性乳腺癌中Ki-67及P53表达的相关性]

[Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].

作者信息

Fang Qi, Wang Xue-fen

机构信息

Department of Breast Surgery, Third Affiliated Hospital of Suzhou University, Changzhou 213000, China.

出版信息

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Feb;31(2):380-2.

PMID:21354936
Abstract

OBJECTIVE

To investigate the relation of CerbB-2 with Ki-67 and P53 expressions in hormone-independent breast cancer.

METHODS

A total of 180 patients with breast cancer were examined for the positivity to estrogen receptor (ER) and progesterone receptor (PR), and subsequently divided into hormone-dependent group (positive for both ER and PR) and hormone-independent group (negative for both). CerbB-2, Ki-67 and P53 expressions were detected in these patients using an improved Envision immunohistochemical staining with the corresponding antibodies. Twenty-nine patients without definite immunohistochemical results of C-erbB-2 were excluded from further analysis. The 51 hormone-independent and 100 hormone-dependent cases were analyzed for the correlation of CerbB-2 to Ki-67 and P53 expressions.

RESULTS

In hormone-independent cases negative for CerbB-2, Ki-67 and P53 expressions were significantly higher than that in hormone-dependent CerbB-2-negative cases (P<0.05), but in CerbB-2-positive cases, their expressions showed no significant differences (P>0.05) with respect to hormonal dependence.

CONCLUSION

In hormone-independent CerbB-2-negative cases, the tumor cells show a higher proliferative activity and P53 expression than those in hormone-dependent cases, which can be an important reason for the high malignancy and poor prognosis of hormone-independent breast cancer negative for CerbB-2.

摘要

目的

探讨激素非依赖性乳腺癌中C-erbB-2与Ki-67及P53表达的关系。

方法

对180例乳腺癌患者检测雌激素受体(ER)和孕激素受体(PR)的阳性情况,随后分为激素依赖性组(ER和PR均阳性)和激素非依赖性组(ER和PR均阴性)。采用改良的Envision免疫组化染色法及相应抗体检测这些患者的C-erbB-2、Ki-67和P53表达。29例C-erbB-2免疫组化结果不明确的患者被排除在进一步分析之外。对51例激素非依赖性和100例激素依赖性病例分析C-erbB-2与Ki-67及P53表达的相关性。

结果

在激素非依赖性病例中,C-erbB-2阴性者的Ki-67和P53表达显著高于激素依赖性C-erbB-2阴性病例(P<0.05),但在C-erbB-2阳性病例中,其表达在激素依赖性方面无显著差异(P>0.05)。

结论

在激素非依赖性C-erbB-2阴性病例中,肿瘤细胞的增殖活性和P53表达高于激素依赖性病例,这可能是激素非依赖性C-erbB-2阴性乳腺癌恶性程度高、预后差的重要原因。

相似文献

1
[Correlation of CerbB-2 to Ki-67 and P53 expressions in hormone-independent breast cancer].[CerbB-2与激素非依赖性乳腺癌中Ki-67及P53表达的相关性]
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Feb;31(2):380-2.
2
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.356例腋窝淋巴结阴性乳腺癌中p53、c-erbB-2、拓扑异构酶IIα表达、DNA倍体、激素受体状态及增殖之间的相关性:预后意义
J Pathol. 1999 Jan;187(2):207-16. doi: 10.1002/(SICI)1096-9896(199901)187:2<207::AID-PATH223>3.0.CO;2-U.
3
Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.雌激素受体、孕激素受体、Ki67、c-erbB-2及p53在子宫内膜癌中的预后意义
J Med Assoc Thai. 2008 Dec;91(12):1779-84.
4
[Effect of neoadjuvant chemotherapy on estrogen and progesterone receptors and P53 and CerbB-2 in breast cancer].[新辅助化疗对乳腺癌雌激素和孕激素受体及P53和CerbB-2的影响]
Zhonghua Yi Xue Za Zhi. 2007 Oct 30;87(40):2843-5.
5
Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.乳腺癌中细胞增殖(Ki-67)与99mTc-(V)二巯基丁二酸摄取的关系。
Breast Cancer Res. 2004;6(2):R56-62. doi: 10.1186/bcr751. Epub 2003 Dec 11.
6
Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.男性乳腺癌:雌激素受体、孕激素受体、Ki-67、人表皮生长因子受体2及p53与治疗和生存的相关性,65例病例研究
Mod Pathol. 2002 Aug;15(8):853-61. doi: 10.1097/01.MP.0000022251.61944.1D.
7
Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program.在乳腺癌筛查项目中选择的无淋巴结转移乳腺癌人群中,肿瘤大小与 Ki-67、p53 和 BCL2 的免疫组化表达之间的关系。
Anticancer Res. 2014 Jan;34(1):269-73.
8
Breast cancer immunohistochemical features in young women with BRCA 1/2 mutations.携带BRCA 1/2基因突变的年轻女性乳腺癌的免疫组化特征
Exp Oncol. 2009 Sep;31(3):174-8.
9
Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.Bcl-2蛋白表达与乳腺癌中的p27和p53蛋白表达以及MIB-1计数相关。
BMC Cancer. 2006 Jul 13;6:187. doi: 10.1186/1471-2407-6-187.
10
Hormone receptor status rather than HER2 status is significantly associated with increased Ki-67 and p53 expression in triple-negative breast carcinomas, and high expression of Ki-67 but not p53 is significantly associated with axillary nodal metastasis in triple-negative and high-grade non-triple-negative breast carcinomas.激素受体状态而非 HER2 状态与三阴性乳腺癌中 Ki-67 和 p53 表达的增加显著相关,而 Ki-67 的高表达而非 p53 的高表达与三阴性和高级别非三阴性乳腺癌中的腋窝淋巴结转移显著相关。
Am J Clin Pathol. 2011 Feb;135(2):230-7. doi: 10.1309/AJCP9DV3EVZUATFV.